Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • pkharchenko
    Junior Member
    • Feb 2012
    • 2

    Postdoctoral Position in Epigenetic Analysis at the Harvard Medical School

    Description: A laboratory at the Center for Biomedical Informatics at the Harvard Medical School (HMS) is looking for a postdoctoral Research Associate interested in computational analysis of epigenetic mechanisms disrupted in cancer and other disease tissues. The Research Associate will be responsible for developing and applying statistical and computational methods for integrative analysis of genome-wide epigenetic, transcriptional and proteomic data, aiming to identify specific factors and molecular mechanisms underlying misregulation of the epigenetic states. The projects are being conducted in close cooperation with several experimental laboratories, providing an excellent opportunity for collaborative research.

    Requirements:
    - Hands-on experience with DNA or RNA sequencing assays
    - Good understanding of the basic statistical techniques
    - A strong interest in conducting collaborative research on the topics outlined above
    - Track record of publications in peer-reviewed journals
    - PhD degree in Molecular Biology, Computational Biology, or a related discipline.

    How to apply: Please send cover letter, curriculum vitae and contact information for at least two references to Dr. Peter Kharchenko at [email protected]. Applications will be considered until the position is filled.

    Employer: Center for Biomedical Informatics, soon to be Department of Biomedical Informatics, promotes development and application of computational and informatics techniques in collaboration with researchers at HMS and its affiliated institutions. Its core faculty members conduct research at the intersection of biomedicine and information sciences, including bioinformatics, functional genomics, translational medicine, and clinical knowledge management. The center also hosts the Bioinformatics & Integrative Genomics PhD program (sponsored by NHGRI) and the Biomedical Informatics Research Training program (a consortium of informatics laboratories at Harvard and MIT, sponsored by NLM).

    Harvard Medical School is an Equal Opportunity/Affirmative Action Employer.
    Women and minorities are especially encouraged to apply.

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    Yesterday, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:10 AM
0 responses
9 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
30 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
40 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Working...